Chronic Rhinosinusitis Trial, Not Yet Recruiting NCT06231004 Sponsor: The First Affiliated Hospital with Nanjing Medical University Condition: Chronic Rhinosinusitis
Back to Chronic Rhinosinusitis

Chronic Rhinosinusitis Trial, Not Yet Recruiting

NCT06231004
Not Yet Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You have been diagnosed with chronic rhinosinusitis with nasal polyps (a condition where the sinuses are chronically inflamed and nasal polyps have grown), confirmed using standard medical guidelines
  • Your nasal polyps show a high level of a specific type of immune cell (eosinophils make up more than 27% of the cells found in the tissue)
  • OR you are having surgery to straighten a deviated nasal septum (a crooked wall inside the nose) and have no other nasal conditions — this would be as a comparison/control participant
  • You have stopped taking steroid medications (whether swallowed or inhaled as a spray) and leukotriene-blocking medications for at least 4 weeks before your biopsy or surgery

Who may not be able to join:

  • You have been diagnosed with any of the following: polyps in the back of the upper jaw sinus, cystic fibrosis, fungal sinus infection, a condition affecting how the tiny hairs in your airways move (primary ciliary dyskinesia), hay fever/allergic rhinitis, a weakened immune system, or a blood clotting disorder
  • You have a sensitivity or intolerance to aspirin that causes nasal/respiratory symptoms (sometimes called AERD or aspirin-exacerbated respiratory disease)
  • You are a smoker
  • You are pregnant

⚠️ Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Lei Cheng, The First Affiliated Hospital, Nanjing Medical University

Phone: 0086-13776620807

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Not Yet Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
22 January 2024
Est. completion
1 September 2026

Primary endpoints

Nasal polyp size after glucocorticosteroid; endoscopic evidence of returned polyposis

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov